Which Should Be Used First for ALK-Positive Non-Small-Cell Lung Cancer: Chemotherapy or Targeted Therapy? A Meta-Analysis of Five Randomized Trials
<i>Background and objectives:</i> Targeted therapy is widely used in the era of precision medicine. Whether the sequence in which targeted therapy and chemotherapy are performed matters, is however not known. We examined the impact of the sequential treatment of targeted therapy and chem...
Main Authors: | Yen-Chien Lee, Chung-Cheng Hsieh, Yen-Ling Lee, Chung-Yi Li |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-01-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1010-660X/55/2/29 |
Similar Items
-
Effectiveness of multi-drug regimen chemotherapy treatment in osteosarcoma patients: a network meta-analysis of randomized controlled trials
by: Xiaojie Wang, et al.
Published: (2017-03-01) -
Impact of adjuvant chemotherapy on outcomes in appendiceal cancer
by: Bhaskar C. Kolla, et al.
Published: (2020-05-01) -
Experience of targeted therapy for ALK positive non-small cell lung cancer – a clinical case
by: A. V. Sultanbaev, et al.
Published: (2020-12-01) -
Cisplatin-based chemotherapy with or without bevacizumab for Chinese postmenopausal women with advanced cervical cancer: a retrospective observational study
by: Xiaoli He, et al.
Published: (2020-05-01) -
Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung Cancer
by: Mei Elsayed, et al.
Published: (2021-04-01)